FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to clinical laboratory medicine, and concerns the method for predicting the effectiveness of treatment of hepatitis C in children of first year of life. Practice essentials: before starting the antiviral therapy in a child polymorphism of genes is determined, coding IL28 (γIFN) rs809917 and rs12979860, and in the presence of: - homozygous forms [TT] for the gene rs809917 and [CC] for the gene rs12979860 - prognosis is laudable, - forms [TG] or [GG] for the gene rs809917 and [TT] or [CT] gene rs12979860 - unfavorable prognosis .MEthod allows in advance, prior to treatment, to adjust therapy, to predict its effectiveness and, thus, to identify a group of children, for that therapy is strictly indicated because of the very high chance of a cure before the onset of complications, and a group for that the chance for success of the therapy is minimal, and, taking into consideration the duration and relative cost of drugs in case of absence of efficacy, treatment is not advisable.
EFFECT: proposed method is simple and can be widely used in clinical practice in hospitals and diagnostic centers.
1 cl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING FAST VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2013 |
|
RU2563812C2 |
METHOD FOR PREDICTION OF RELIABILITY OF RESPONSE TO ROUTINE TWO-COMPONENT ANTIRETROVIRAL THERAPY WITH PEGYLATED INTERFERONS AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1B | 2014 |
|
RU2578030C2 |
PREDICTION OF KINETICS OF HEPATITIS C VIRUS IN INTERFERON-EXCLUDING TREATMENT | 2011 |
|
RU2590691C2 |
METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC VIRAL HEPATITIS C | 2013 |
|
RU2546032C2 |
METHOD FOR INDIVIDUAL PREDICTION OF THERAPEUTIC EFFICACY OF CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON ALPHA AND RIBAVIRIN | 2013 |
|
RU2525159C1 |
METHOD FOR PREDICTION OF LIVER FIBROSIS DYNAMICS IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE 1, NOT RESPONDING TO TREATMENT WITH PEGYLATED INTERFERONS AND RIBAVIRIN | 2015 |
|
RU2623151C2 |
SINGLE NUCLEOTIDE POLYMORPHISM ON CHROMOSOME 15 ENABLING PREDICTION OF HCV TREATMENT RESPONSES | 2012 |
|
RU2606759C2 |
SINGLE NUCLEOTIDE POLYMORPHISMS FOR PREDICTING RESULTS OF TREATMENT OF HEPATIC C VIRUS INFECTION | 2011 |
|
RU2567663C2 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF INTERFERON THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2012 |
|
RU2486526C1 |
METHOD OF PREDICTING EFFICIENCY OF COMBINED THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2014 |
|
RU2564933C1 |
Authors
Dates
2018-03-05—Published
2016-11-03—Filed